subject: MarketsandMarkets: Global Biomarker Market Worth US$ 20.5 Billion By 2014 [print this page] The Healthcare practice at MarketsandMarkets is pleased to announce its Analyst Briefing Presentation on the Global Biomarker Market to be held on 11th September, 2009. The briefing on the Global Biomarker market (2009-2014) will benefit the Active pharmaceutical ingredients (APIs) manufacturers, contract research organizations, drug manufacturers, medical/pharma associations, research labs, healthcare service providers, regulatory authorities, and technology providers.
MarketsandMarkets: Global Biomarker Market Worth US$ 20.5 Billion By 2014
By: Ms. Sunita
welcome to Insurances.net (https://www.insurances.net)
